United States
Germany
Japan
United Kingdom
China
FXYD3 mouse monoclonal antibody, clone OTI2F7 (formerly 2F7)
| Applications | WB |
| Reactivities | Human |
Products
FXYD3 mouse monoclonal antibody, clone OTI4E3 (formerly 4E3)
| Applications | IF, IHC, WB |
| Reactivities | Human |
FXYD3 mouse monoclonal antibody, clone OTI1A8 (formerly 1A8)
| Applications | WB |
| Reactivities | Human |
FXYD3 mouse monoclonal antibody, clone OTI1G3 (formerly 1G3)
| Applications | WB |
| Reactivities | Human |
FXYD3 mouse monoclonal antibody, clone OTI3D8 (formerly 3D8)
| Applications | WB |
| Reactivities | Human |
FXYD3 mouse monoclonal antibody, clone OTI1D1 (formerly 1D1)
| Applications | FC, IF, WB |
| Reactivities | Human |
FXYD3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
FXYD3 (untagged)-Human FXYD domain containing ion transport regulator 3 (FXYD3), transcript variant 1
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-XL5 |
FXYD3 mouse monoclonal antibody, clone OTI1A8 (formerly 1A8)
| Applications | WB |
| Reactivities | Human |
FXYD3 mouse monoclonal antibody, clone OTI2F7 (formerly 2F7)
| Applications | WB |
| Reactivities | Human |
FXYD3 mouse monoclonal antibody, clone OTI1G3 (formerly 1G3)
| Applications | WB |
| Reactivities | Human |
FXYD3 mouse monoclonal antibody, clone OTI3D8 (formerly 3D8)
| Applications | WB |
| Reactivities | Human |
